VIENNA, Va., June 18, 2024--CEL-SCI Corporation (NYSE American: CVM) today announced the Company’s Chief Scientific Officer, Dr. Eyal Talor, delivered a presentation titled "Neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback